Michael Adam Fischer MD, MS

Professor, General Internal Medicine

Section Chief, General Internal Medicine

801 Massachusetts Ave | (617) 414-7288
Michael Fischer
Sections

General Internal Medicine

Biography

Michael Fischer, MD, MS is Chief of the Section of General Internal Medicine at Boston Medical Center/Chobanian and Avedisian School of Medicine. He is a primary care physician and health services researcher with expertise in developing and evaluating interventions to increase the use of evidence-based medical practices.

Dr. Fischer began his career at Brigham and Women’s Hospital, conducting research evaluating medication adherence; the appropriate use of prescription drugs; dissemination and implementation of evidence-based practices; prescription drug reimbursement policy; and the impact of electronic prescribing. He is the Director of the National Resource Center for Academic Detailing (www.NaRCAD.org), an initiative supported by the Agency for Health Care Research and Quality and the Centers for Disease Control and Prevention to assist organizations implementing interventions to improve health care quality and patient outcomes.

Websites

BU Profile

NCBI Bibliography

Section of General Internal Medicine

National Resource Center for Academic Detailing

Education

Medicine, MD, Yale University School of Medicine

Health Policy Management, MS, Harvard School of Public Health

Social Studies, AB, Harvard College

Publications

Published on 11/20/2023

Cromer SJ, Steiner B, York C, Mastrorilli J, Lake GA, Leibowitz S, Simmons L, Steppel-Reznik J, Low G, Fischer MA, Patorno E, Wexler DJ. Successful implementation of a stakeholder engagement program for pharmacoepidemiologic research. Pharmacoepidemiol Drug Saf. 2024 Jan; 33(1):e5727. PMID: 37985010.

PubMed
Published on 7/27/2023

Brown T, Lee JY, Guzman A, Fischer MA, Friedberg MW, Chua KP, Linder JA. Prevalence and appropriateness of in-person versus not-in-person ambulatory antibiotic prescribing in an integrated academic health system: A cohort study. PLoS One. 2023; 18(7):e0289303. PMID: 37498818.

PubMed
Published on 3/1/2023

Hendricks MA, El Ibrahimi S, Ritter GA, Flores D, Fischer MA, Weiss RD, Wright DA, Weiner SG. Association of Household Opioid Availability With Opioid Overdose. JAMA Netw Open. 2023 Mar 01; 6(3):e233385. PMID: 36930154.

PubMed
Published on 11/9/2022

Evins AE, Cather C, Maravic MC, Reyering S, Pachas GN, Thorndike AN, Levy DE, Fung V, Fischer MA, Schnitzer K, Pratt S, Fetters MD, Deeb B, Potter K, Schoenfeld DA. A Pragmatic Cluster-Randomized Trial of Provider Education and Community Health Worker Support for Tobacco Cessation. Psychiatr Serv. 2023 Apr 01; 74(4):365-373. PMID: 36349498.

PubMed
Published on 11/4/2022

Guzman A, Brown T, Lee JY, Fischer MA, Friedberg MW, Chua KP, Linder JA. Look-Back and Look-Forward Durations and the Apparent Appropriateness of Ambulatory Antibiotic Prescribing. Antibiotics (Basel). 2022 Nov 04; 11(11). PMID: 36358209.

PubMed
Published on 10/28/2022

Haff N, Choudhry NK, Isaac T, Bhatkhande G, Jackevicius CA, Fischer MA, Solomon DH, Sequist TD, Lauffenburger JC. Disagreement between pharmacy claims and direct interview to identify patients with non-adherence to chronic cardiometabolic medications. Am Heart J. 2023 Feb; 256:51-59. PMID: 36780373.

PubMed
Published on 10/4/2022

Wang J, Gagne JJ, Kattinakere-Sreedhara S, Fischer MA, Bykov K. Association between initiation of fluoroquinolones and hospital admission or emergency department visit for suicidality: population based cohort study. BMJ. 2022 Oct 04; 379:e069931. PMID: 36195324.

PubMed
Published on 9/29/2022

Messinger JC, Kesselheim AS, Vine SM, Fischer MA, Barenie RE. Associations Between Copays, Coverage Limits for Naloxone, and Prescribing in Medicaid. Subst Abuse. 2022; 16:11782218221126972. PMID: 36199698.

PubMed
Published on 4/5/2022

Weiner SG, Hendricks MA, El Ibrahimi S, Ritter GA, Hallvik SE, Hildebran C, Weiss RD, Boyer EW, Flores DP, Nelson LS, Kreiner PW, Fischer MA. Opioid-related overdose and chronic use following an initial prescription of hydrocodone versus oxycodone. PLoS One. 2022; 17(4):e0266561. PMID: 35381052.

PubMed
Published on 1/21/2022

Cram P, Selker H, Carnahan J, Romero-Brufau S, Fischer MA. Getting to 100%: Research Priorities and Unanswered Questions to Inform the US Debate on Universal Health Insurance Coverage. J Gen Intern Med. 2022 03; 37(4):949-953. PMID: 35060003.

PubMed
View full list of 166 publications.

View all profiles